Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |